Biodexa Pharmaceuticals Plc (NASDAQ:BDRX) Short Interest Up 15.9% in November

Biodexa Pharmaceuticals Plc (NASDAQ:BDRX) was the target of a significant increase in short interest during the month of November. As of November 15th, there was short interest totalling 16,000 shares, an increase of 15.9% from the October 31st total of 13,800 shares. Based on an average trading volume of 255,500 shares, the days-to-cover ratio is currently 0.1 days.

Biodexa Pharmaceuticals Stock Performance

NASDAQ BDRX traded up $0.12 during trading hours on Monday, reaching $5.74. 14,700 shares of the stock traded hands, compared to its average volume of 149,714. Biodexa Pharmaceuticals has a 1 year low of $3.50 and a 1 year high of $103.00.

About Biodexa Pharmaceuticals

Biodexa Pharmaceuticals Plc, a clinical stage biopharmaceutical company, focuses on developing a pipeline of products for the treatment of Type 1 diabetes and rare/orphan cancers of the brain. Its lead product candidate Tolimidone, a selective activator of the lyn kinase enzyme, currently under Phase II studies for the treatment of Type 1 diabetes.